Two companies in the consumer discretionary sector faced a troubling decline on Monday.
Investors grew increasingly wary about Keurig Dr Pepper (KDP) buying JDE Peet’s. BNS Paribas analyst Kevin Gundy warned that stock markets are not reacting well to the acquisition. KDP stock closed at a multi-year low, closing at $25.95 on Monday.
The analyst believes that business risks will worsen. Elastic demand for coffee and soda drinks is the major headwind.
The breakout in Match (MTCH) Group began in March at around $27 and peaked at around $38.74. After MTCH stock lost 5.4% yesterday, the selling momentum might accelerate from here. Meta added a dating feature that is rolling out in the U.S. and Canada. “Meet Cute” will offer the user a “surprise match.” Users would get such matches weekly. That would challenge Tinder’s “right swipe.”
Kenvue (KVUE) fell after the Trump Administration reportedly planned to report on a link between Tylenol and autism risks.
The White House might claim the painkiller pill and autism. It might also promote leucovorin, a drug used alongside cancer treatments, as a possible therapy for autism.
J&J (JNJ) fared well, spinning off the liabilities related to Tylenol with Kenvue. This insulates J&J from any potential legal costs.
Related Stories
